245 related articles for article (PubMed ID: 26763764)
1. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
2. Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Hung N; Hung CT; Harland S; Devane J; Crockett RS; Howes J; Darpo B; Zhou M; Weis H; Friedhoff L
Clin Pharmacol Drug Dev; 2016 Nov; 5(6):460-468. PubMed ID: 27870477
[TBL] [Abstract][Full Text] [Related]
3. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
4. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
6. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
[TBL] [Abstract][Full Text] [Related]
7. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment.
Winklbaur B; Jagsch R; Ebner N; Thau K; Fischer G
Eur Addict Res; 2008; 14(2):99-105. PubMed ID: 18334820
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy.
Eder H; Jagsch R; Kraigher D; Primorac A; Ebner N; Fischer G
Addiction; 2005 Aug; 100(8):1101-9. PubMed ID: 16042640
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. The role of methadone in opioid rotation-a Polish experience.
Leppert W
Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
[TBL] [Abstract][Full Text] [Related]
16. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
17. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations.
Athanasos P; Smith CS; White JM; Somogyi AA; Bochner F; Ling W
Pain; 2006 Feb; 120(3):267-275. PubMed ID: 16427197
[TBL] [Abstract][Full Text] [Related]
18. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
Fredheim OM; Borchgrevink PC; Klepstad P; Kaasa S; Dale O
Eur J Pain; 2007 Aug; 11(6):599-604. PubMed ID: 17113329
[TBL] [Abstract][Full Text] [Related]
19. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
20. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
